Sarcopenia markedly increases the risk of major complications and lowers overall survival in patients with gastrointestinal cancer. An umbrella review of 63 studies reveals that 65% identify sarcopenia as a risk factor for severe postoperative issues, while 93% correlate it with diminished survival rates. With strong evidence backing these findings, addressing sarcopenia could be crucial in enhancing patient management and outcomes. Early identification may lead to vital therapeutic interventions that improve recovery and longevity.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.